Invista North America S.À.R.L. v. Rhodia Polyamide Intermediates S.A.S.

503 F. Supp. 2d 195, 2007 U.S. Dist. LEXIS 56601, 2007 WL 2230273
CourtDistrict Court, District of Columbia
DecidedAugust 6, 2007
DocketCivil Action 06-2180 (RCL)
StatusPublished
Cited by10 cases

This text of 503 F. Supp. 2d 195 (Invista North America S.À.R.L. v. Rhodia Polyamide Intermediates S.A.S.) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Invista North America S.À.R.L. v. Rhodia Polyamide Intermediates S.A.S., 503 F. Supp. 2d 195, 2007 U.S. Dist. LEXIS 56601, 2007 WL 2230273 (D.D.C. 2007).

Opinion

MEMORANDUM OPINION

LAMBERTH, District Judge.

I. INTRODUCTION

This matter comes before the Court on defendant Rhodia Polyamide Intermediates S.A.S.’s (“Rhodia PI”) motion [8] to compel arbitration. Upon consideration of Rhodia Pi’s motion, plaintiff INVISTA North America S.á.r.l.’s (“INVISTA NA”) opposition [13] thereto, Rhodia Pi’s reply [14], INVISTA NA’s sur-reply [16], the applicable law, and the record herein, the Court will grant Rhodia Pi’s motion [8] to compel arbitration.

II. BACKGROUND

In 1998, E.I. DuPont de Nemours and Co. (“DuPont”) entered into a licensing agreement with Butachimie, a joint venture between DuPont and Rhodianyl, regarding advanced technology (“Gen III technology”) used in the production of nylon fiber. (Pl.’s Comp. ¶ 13.) As part of the licensing agreement, the two parties entered into a Confidentiality Agreement to prohibit various Rhodia Group entities, including Rhodianyl, from disclosing or using confidential Gen III technology for their own purposes. (Def.’s Mot. to Compel Ex. 1. ¶2. 1.) In addition, the Confidentiality Agreement prohibits Rhodia Group signatories from using, any confidential information regarding Gen III technology in a patent application absent limited exceptions. (Id. ¶ 3.2.) If any confidential information is used by a Rho-dia Group signatory, the patent application must be assigned to DuPont, the inventor of the Gen III technology. (Id.) Furthermore, in the Confidentiality Agreement *199 the parties agreed to settle any dispute arising out of the agreement through arbitration. (Id. ¶ 5.1.)

Following the execution of the Confidentiality Agreement, DuPont scientists gave a series of presentations to scientists of Rhodianyl and other Rhodia Group entities, including Rhodia PI. (Pl.’s Comp. ¶¶ 14-16.) These presentations contained confidential information regarding the Gen III process. (See id.) After evaluating the technology, Rhodianyl did not implement the Gen III technology at Butachi-mie. (Pl.’s Opp’n to Def.’s Mot. to Compel [hereinafter Pl.’s Opp’n] at 4.)

In 2004, DuPont assigned its rights in the Confidentiality Agreement to INVIS-TA NA. (Def.’s Mot. to Compel, Ex. 2 ¶ 9.) In 2005, INVISTA NA discovered that Rhodia PI, a subsidiary of Rhodianyl that is not a signatory to the Confidentiality Agreement, applied for U.S. Patent No. 7,084,293 (“the '293 Patent”) and other related patents that allegedly contain confidential Gen III technology. (Pl.’s Opp’n at 5.) Furthermore, INVISTA NA alleges that the '293 Patent incorrectly names Rhodia PI employees as the inventors of the Gen III technology in place of the DuPont scientists who developed this technology. (Pl.’s Comp. ¶ 4.) INVISTA NA and Rhodia PI attempted to resolve the dispute concerning the inventorship of the '293 Patent and the ownership of the related patents without judicial intervention for over a year. (PL’s Opp’n at 5.) Ultimately, however, the negotiations failed, and IN-VISTA NA filed this suit seeking a court order, pursuant to 35 U.S.C. § 256 (“Section 256”), 1 replacing the names of the inventors on the '293 Patent with the names of the DuPont scientists who allegedly developed the technology contained in the '293 Patent. (PL’s Comp. ¶¶ 34-40.) INVISTA NA also seeks to enjoin Rhodia PI from including any confidential information relating to the Gen III technology in other patent applications. (Id. ¶44.) Moreover, INVISTA NA asks the Court to place the '293 Patent in a constructive trust along with any other patents which contain INVISTA NA’s confidential information. (Id. ¶¶ 45-47.)

In addition to the present suit, INVIS-TA NA initiated arbitration against Rho-dianyl and Rhodia PI for including confidential information regarding the Gen III technology in the patent applications held by Rhodia PI. (See Def.’s Mot. to Compel Ex. 2.) INVISTA NA requests the arbitral tribunal to declare that Rhodia PI breached the confidentiality agreement when it filed the patents and to order Rhodia PI to assign the '293 and related patents to IN-VISTA NA. (Id. ¶ 45.) INVISTA NA also seeks to enjoin Rhodia PI from disclosing or using any further confidential information protected by the Confidentiality Agreement. (Id.)

Rhodia PI has also initiated arbitration against INVISTA NA. (See Def.’s Mot. to Compel Ex. 3.) Rhodia PI asks the arbitral tribunal to declare that the disputed patent applications do not contain any confidential information protected by the Confidentiality Agreement. (Id. ¶ 30.)

Rhodia PI now moves this Court to compel INVISTA NA to pursue the claims in its complaint in the pending arbitration proceedings pursuant to 9 U.S.C. § 4 because INVISTA NA’s claims are within the scope of the arbitration agreement and because the relief sought is nearly identical to the relief sought in arbitration. *200 (Def.’s Mot. to Compel at 1.) In the alternative, Rhodia PI asks this Court to stay the proceedings pursuant to 9 U.S.C. § 3 until the arbitral tribunal enters a final award. (Id.) In addition, if the Court grants Rhodia Pi’s motion to compel arbitration, INVISTA NA requests the Court to stay these proceedings until after the pending arbitration is resolved. (Pl.’s Opp’n at 28.)

III. LEGAL STANDARD

The Federal Arbitration Act (“FAA”) provides that “a written provision in ... a contract to settle by arbitration a controversy thereafter arising out of such contract ... shall be valid, irrevocable, and enforceable save upon any grounds as exist at law or in equity for revocation of any contract.” 9 U.S.C. § 2; Stromberg Sheet Metal Works, Inc. v. Washington Gas Energy Systems, Inc., 448 F.Supp.2d 64, 67 (D.D.C.2006). The FAA creates a strong presumption in favor of arbitration. See Moses. H. Cone Memorial Hosp. v. Mercury Const. Corp., 460 U.S. 1, 24-25, 103 S.Ct. 927, 74 L.Ed.2d 765 (1983). Accordingly, courts should resolve “any doubts concerning the scope of arbitrable issues ... in favor of arbitration.” Id. Parties, however, cannot be forced into arbitration without an agreement to do so, and the authority of arbitrators to resolve disputes arises out of an agreement between the parties to engage in arbitration. See AT & T Techs. Inc. v. Commc’ns Workers of America, 475 U.S. 643, 650, 106 S.Ct. 1415, 89 L.Ed.2d 648 (1986); Stromberg, 448 F.Supp.2d at 67.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Johnson v. Acb Ideas, LLC
District of Columbia, 2024
Schwartz v. Urban Compass, Inc
District of Columbia, 2020
Nanko Shipping, USA v. Alcoa, Inc.
District of Columbia, 2018
Nanko Shipping v. Alcoa, Inc.
330 F. Supp. 3d 439 (D.C. Circuit, 2018)
Johansson v. Cent. Props., LLC
320 F. Supp. 3d 218 (D.C. Circuit, 2018)
Johansson v. Central Properties, LLC
District of Columbia, 2018
Newco Ltd. v. Government of Belize
156 F. Supp. 3d 79 (District of Columbia, 2015)
Sheet Metal Workers' International Ass'n v. United Transportation Union
767 F. Supp. 2d 161 (District of Columbia, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
503 F. Supp. 2d 195, 2007 U.S. Dist. LEXIS 56601, 2007 WL 2230273, Counsel Stack Legal Research, https://law.counselstack.com/opinion/invista-north-america-sarl-v-rhodia-polyamide-intermediates-sas-dcd-2007.